TrialInternational journal of chronic obstructive pulmonary disease

Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA.

Brian J Lipworth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.